On October 1, 2026, CARE Ratings Nepal listed a revised issuer rating for Kamana Sewa Bikas Bank Limited: CARE-NP BBB-(Is), up from CARE-NP BB+(Is). It is one notch, and it matters, because BBB- is where the investment-grade scale begins: issuers at this level are, in the agency's own definition, considered to offer a moderate degree of safety regarding timely servicing of financial obligations and carry moderate credit risk. The KSBBL CARE rating upgrade crosses that line. Here is the honest version: the press release, dated September 2026 and published on the agency's official ratings page, credits improved capitalization, better earnings quality, and asset quality that held up better than the industry's. But it also says, plainly, that the earnings gain reflects funding management and contained credit costs rather than revenue growth, and so remains sensitive to the interest rate cycle.
The capital story is the strongest leg. KSBBL, a national-level class B development bank formed by the August 2017 merger of Kamana Bikas Bank and Sewa Bikas Bank, raised its overall capital adequacy ratio to 14.16% in FY26 from 12.58% in FY25, per the press release, while the Tier I ratio rose 177 basis points to 11.68%. The driver was not just retained earnings: the bank issued Rs 350 million in perpetual non-cumulative preference shares qualifying as Additional Tier I capital, a deliberate capital-market move that gives it, in CARE's words, adequate headroom for growth and shock absorption. With paid-up capital of Rs 4,212 million split 51:49 between promoters and public shareholders, and NRB's minimums for national development banks sitting at 8.5% Tier I and 11% overall CAR, the buffer above the regulatory floor is real.
The earnings leg is where the upgrade gets interesting. Profit after tax rose to Rs 909 million in FY26 from Rs 670 million the year before, and return on total assets reached 1.24% from below unity. But total income fell, to Rs 5,678 million from Rs 6,361 million, because falling interest rates compressed lending yields about 170 basis points sector-wide. The bank made it work on the other side of the balance sheet: the cost of deposits fell about 140 basis points, helped by a decisive shift toward low-cost deposits, and the current-and-savings (CASA) ratio jumped to 53.79% from 36.43% a year earlier. Net interest margin held at 3.32% against 3.34%. Impairment charges dropped to Rs 142 million from Rs 418 million. In plain terms, the bank defended its margin by borrowing cheaper, not by lending better, a distinction CARE itself draws when it warns the gain remains sensitive to the interest rate cycle.
On asset quality, the bank's numbers read better than the industry's, which is exactly what the rater leans on. Gross non-performing loans rose to 3.78% from 3.49%, but the industry average sits at 5.77%, and CARE notes the increase is partly an accounting effect of a new NRB curing rule that keeps a loan in the NPL bucket until six months of clean repayments: adjusted for that, the ratio would be 3.31%, below last year's. Early-stage delinquency improved, with 30-days-past-due loans down to 13.15% from 13.97%. Deposits grew 5.10% to Rs 66,744 million, advances grew 6.29%, slightly ahead of the industry's 5.69%, and the bank holds just over a tenth of the class-B segment's deposits and loans. Liquidity is comfortable: SLR 23.22% against a 10% requirement, net liquidity ratio 25.12% against a 20% threshold.
For NEPSE investors, what does a rating upgrade actually buy? It does not change the share price by itself, and CARE's disclaimer says plainly that its ratings are opinions on credit quality, not recommendations to buy, sell, or hold any security. What changes is the bank's standing with counterparties: a BBB- issuer rating signals moderate credit risk to depositors and wholesale lenders, which can lower the cost at which the bank itself borrows and deepen its access to institutional money. The constraints the rater keeps on the table are equally concrete: an elevated, if manageable, NPL ratio; a crowded field of 17 development banks operating 1,112 branches; and the structural regulatory risk of a sector where NRB's rule changes move capital requirements, risk weights, and provisioning overnight. The key rating sensitivities CARE names going forward are the bank's ability to grow profitably, improve asset quality, keep adequate cushion above regulatory minimums, and absorb whatever NRB changes next.
The open question is durability. KSBBL's upgrade rests on two pillars that are cyclical by nature: cheap deposits and contained credit costs. If interest rates turn, the CASA advantage that protected the margin can compress, and the NPL trajectory that improved this year can reverse with the next downturn in borrower repayment capacity. The bank has bought itself headroom with the Tier I issuance and the margin discipline; whether that headroom turns into structurally better profitability, or merely carries it through one more rate cycle, is what the next two quarters of reported numbers will show. For now, the rater's verdict stands: one notch up, into investment grade, on the strength of a balance sheet that is better capitalized and better funded than it was a year ago.
This article is research and education, not investment advice. It is based on CARE Ratings Nepal's official press release for Kamana Sewa Bikas Bank Limited, dated September 2026 and listed on the agency's website on October 1, 2026. CARE's ratings are opinions on credit quality, not recommendations to buy, sell, or hold any security. Figures are as stated in the press release; verify against the agency's official publications before acting.